Influence of pharmacogenetic polymorphisms and demographic variables on metformin pharmacokinetics in an admixed Brazilian cohort

No abstract is available for this paper.

• Publication year

  2018

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bcp.13522PMID 29352482PMCID PMC5903234
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metformin

  2019cited by this paper
• Influence of pharmacogenetic polymorphisms and demographic variables on metformin pharmacokinetics in an admixed Brazilian cohort

  2018cited by this paper
• Genetic Polymorphisms in Organic Cation Transporter 1 Attenuates Hepatic Metformin Exposure in Humans

  2017cited by this paper
• Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta‐Analysis

  2017cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

  2017cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters

  2017cited by this paper
• Transporters Involved in Metformin Pharmacokinetics and Treatment Response.

  2017cited by this paper
• Variation in the Glucose Transporter gene SLC2A2 is associated with glycaemic response to metformin

  2016cited by this paper
• Limited sampling strategy for determining metformin area under the plasma concentration-time curve.

  2016cited by this paper
• Therapeutic Concentrations of Metformin: A Systematic Review

  2016cited by this paper
• Steady-state pharmacokinetics of metformin is independent of the OCT1 genotype in healthy volunteers

  2015cited by this paper
• Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug–drug interactions

  2015cited by this paper
• A Comprehensive Review of Drug–Drug Interactions with Metformin

  2015cited by this paper
• Genetic Variants in Transcription Factors Are Associated With the Pharmacokinetics and Pharmacodynamics of Metformin

  2014cited by this paper
• Metformin Pharmacogenomics: Current Status and Future Directions

  2014cited by this paper
• An update on the pharmacogenomics of metformin: progress, problems and potential.

  2014cited by this paper
• A gene–gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin

  2013cited by this paper
• Current Status and Future Directions

  2013cited by this paper
• Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin

  2012cited by this paper
• The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c

  2011cited by this paper
• Clinical Pharmacokinetics of Metformin

  2011cited by this paper
• A Common 5′‐UTR Variant in MATE2‐K Is Associated With Poor Response to Metformin

  2011cited by this paper
• The Genomic Ancestry of Individuals from Different Geographical Regions of Brazil Is More Uniform Than Expected

  2011cited by this paper
• Pharmacogenetics in the Brazilian Population

  2010cited by this paper
• Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes

  2010cited by this paper
• Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1

  2009cited by this paper
• The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin

  2009cited by this paper
• Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin Pharmacokinetics

  2008cited by this paper
• Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin

  2008cited by this paper
• Prevalence of chronic kidney disease in the United States.

  2007cited by this paper
• Oral Antidiabetic Drugs: Effect of Food on Absorption of Pioglitazone and Metformin From a Fixed‐Dose Combination Tablet

  2007cited by this paper
• Pharmacogenomics in the Americas: the impact of genetic admixture.

  2006cited by this paper
• The genetic structure of human populations studied through short insertion-deletion polymorphisms.

  2006cited by this paper
• The Genetic Structure of Human Populations Studied Through Short Insertion‐Deletion Polymorphisms

  2006cited by this paper
• FAST‐TRACK: Integrating QTL mapping and genome scans towards the characterization of candidate loci under parallel selection in the lake whitefish (Coregonus clupeaformis)

  2004cited by this paper
• Estimating the contribution of genes and environment to variation in renal drug clearance.

  2003cited by this paper
• Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1

  2003cited by this paper
• A comparison of bayesian methods for haplotype reconstruction from population genotype data.

  2003cited by this paper
• Color and genomic ancestry in Brazilians

  2002cited by this paper
• Pharmacokinetics and Bioavailability of a Metformin/Glyburide Tablet Administered Alone and with Food

  2000cited by this paper
• Extreme discordant phenotype methodology: an intuitive approach to clinical pharmacogenetics.

  2000cited by this paper
• Inference of population structure using multilocus genotype data.

  2000cited by this paper
• Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research.

  1998cited by this paper
• Food intake and dosage level, but not tablet vs solution dosage form, affect the absorption of metformin HC1 in man

  1996cited by this paper
• Food intake and dosage level, but not tablet vs solution dosage form, affect the absorption of metformin HCl in man.

  1996cited by this paper
• Kidney Function and Age Are Both Predictors of Pharmacokinetics of Metformin

  1995cited by this paper

• Pharmacogenetics and Molecular Ancestry of SLC22A1, SLC22A2, SLC22A3, ABCB1, CYP2C8, CYP2C9, and CYP2C19 in Ecuadorian Subjects with Type 2 Diabetes Mellitus

  2025cites this paper
• Exploring the influence of transporter gene polymorphisms on metformin efficacy in type 2 diabetes mellitus: A systematic review

  2025cites this paper
• Genetics and response to treatment with metformin for type 2 diabetes

  2025cites this paper
• Exome Sequence Data of Eight SLC Transporters Reveal That SLC22A1 and SLC22A3 Variants Alter Metformin Pharmacokinetics and Glycemic Control

  2024cites this paper
• Liver Fibrosis Stages Affect Organic Cation Transporter 1/2 Activities in Hepatitis C Virus-Infected Patients

  2024influential citation
• Clinical efficacy and cost‐effectiveness of metformin in different patient populations: A narrative review of real‐world evidence

  2024cites this paper
• A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes

  2023cites this paper
• Influence of Solute Carrier Family 22 Member 1 (SLC22A1) Gene Polymorphism on Metformin Pharmacokinetics and HbA1c Levels: A Systematic Review.

  2023cites this paper
• Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes

  2022cites this paper
• Metformin to treat Huntington disease: a pleiotropic drug against a multi-system disorder.

  2022cites this paper
• Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation.

  2022cites this paper
• Research Progress of Population Pharmacokinetic of Metformin

  2022cites this paper
• Metformin—‘BRAINS & AIMS’ pharmacological/prescribing principles of commonly prescribed (Top 100) drugs: Education and discussion

  2022cites this paper
• Diffusion Mechanism Modeling of Metformin in Human Organic Cationic Amino Acid Transporter one and Functional Impact of S189L, R206C, and G401S Mutation

  2021cites this paper
• Codeine , morphine , and metformin : Common aspects of drug transport , drug-drug interactions , and pharmacogenetics

  2021cites this paper
• Drug Transport—Uptake

  2021cites this paper
• The L125F MATE1 variant enriched in populations of Amerindian origin is associated with increased plasma levels of metformin and lactate.

  2021cites this paper
• Population diversity of three variants of the SLC47A2 gene (MATE2-K transporter) in Mexican Mestizos and Native Americans

  2021cites this paper
• The Impact of Genetic Polymorphisms in Organic Cation Transporters on Renal Drug Disposition

  2020cites this paper
• Using a limited sampling strategy to investigate the interindividual pharmacokinetic variability in metformin: A large prospective trial

  2020cites this paper
• An Artificial Neural Network Approach to Predict the Effects of Formulation and Process Variables on Prednisone Release from a Multipartite System

  2019cites this paper
• Influence of pharmacogenetic polymorphisms and demographic variables on metformin pharmacokinetics in an admixed Brazilian cohort

  2018cites this paper